Given the data and tweets, could you project whether the closing price of $amgn will grow or shrink at 2017-06-07? Please specify either Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-05-23,-0.9,0.3,-1.2,0.7,0.7,1.1,2.3,3.3,3.8,4.0,4.1
2017-05-24,0.1,0.3,-0.5,0.3,0.3,0.4,1.6,2.6,3.2,3.5,3.6
2017-05-25,-0.2,0.4,-0.5,0.5,0.5,-0.5,0.9,1.8,2.4,2.8,2.9
2017-05-26,0.4,0.7,-0.1,-0.3,-0.3,-0.4,0.9,1.7,2.5,3.0,3.0
2017-05-30,0.8,1.0,-0.2,-0.7,-0.7,0.5,1.2,2.1,3.0,3.5,3.6
2017-05-31,-1.0,0.1,-1.0,0.9,0.9,-0.3,0.0,0.9,1.9,2.4,2.6
2017-06-01,-0.5,0.3,-0.6,0.6,0.6,-0.7,-0.7,0.1,1.0,1.5,1.9
2017-06-02,-1.2,0.3,-1.4,1.9,1.9,-2.0,-2.4,-1.7,-1.0,-0.4,-0.0
2017-06-05,0.0,0.6,-1.2,0.7,0.7,-2.0,-2.8,-2.3,-1.7,-1.1,-0.7
2017-06-06,0.4,0.9,-0.2,-0.4,-0.4,-0.9,-2.0,-1.9,-1.4,-0.7,-0.3

2017-05-23: these 3 biotech stocks have ballooned, AT_USER #stocks $pfe, $jnj, $sny, $amgn, $gern, $regn, $ibb, $ptla |rt AT_USER $nwbo tapping on .16 breach of that should see good run #asco17 $amgn $pfe |rt AT_
2017-05-24: $amgn: more insider selling today, no position in the stock.|rt AT_USER $rdus abaloparatide advantages  as compared to teriparatide and $amgn romosozumab in #osteoporosis |$amgn - statement of changes
2017-05-25: since then $amgn #fail - |$amgn the bull pattern is confirmed &amp; a buy signal is issued @  buy level: 155.3500   target: 163.1175|investors sell amgen, inc. $amgn on strength on insider selling |in
2017-05-26: $amgn high open interest range is 150.00 to 165.00 for option expiration 06/02/2017.  |rt AT_USER therapy focus - as cgrp race hots up the only headache could be paying for them  $lly $amgn $nvs $¡­|f
2017-05-27: 3 things in biotech you should learn today: may 27, 2017  $amgn $kite $mrk $pfe|rt AT_USER $spx company insider trades in past 5 days. $wmt $aapl $csco $ice $regn $sre $intu $efx $msft $luv $udr $dhr 
2017-05-28: $amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 highest call.  |safety signal derails expected approval of $amgn bone drug |rt AT_USER #asco2017 is right around the corner. here's what to
2017-05-29: {new video} biotech analysis + trade ideas: $ibb $celg $gild $myl $amgn $agn --&gt;  |more information about $amgn on  #diis #iamnetwork |$amgn oi for maturity 06/02/2017. 150.00 highest put. 165.00 h
2017-05-30: #amgen sues the fda over marketing exclusivity for sensipar in pediatric patients. read more:  $amgn|interview with connor bruggeman schooltrader extraordinaire!:  $nflx $himx $ino $amgn $googl|amgen 
2017-05-31: rt AT_USER these 5 healthcare stocks are undervalued  $hca $amgn $dva #healthcare |rt AT_USER these 5 healthcare stocks are undervalued  $hca $amgn $dva #healthcare |these 5 healthcare stocks are unde
2017-06-01: rt AT_USER ubs:" immuno-oncology  drugs by target : $mrk $bmy $celg $incy $iph.pa $pfe $amgn $ziop $sgne $ino $clsn ..." |rt AT_USER amgen sues the #fda for denying its right to a key marketing incent
2017-06-02: $amgn - statement of changes in beneficial ownership (4) |amgen inc. director just disposed of 3,700 shares   $amgn|$pirs will be to $amgn what #genentech is to AT_USER -licketyspilt - bob bradway too
2017-06-03: amgen's imlygic shows treatment effect in metastatic melanoma patients in mid-stage study  $amgn $bmy #sitifatimah ¡­|amgen's imlygic shows treatment effect in metastatic melanoma patients in mid-stag
2017-06-04: $amgn maturity 06/09/2017 vol putcallratio of 0.96 puts=1,228 calls=1,278 .  |rt AT_USER biotech stocks have surged this week, so here's how AT_USER is betting on $amgn to make profits |$amgn shrugged
2017-06-05: rt AT_USER $rdus has a real breast cancer drug. after $amgn osteoporosis safety concerns, bear case for tymlos weakened.|rt AT_USER lo's of successes at #asco17 #asco2017 $loxo $pbyi $kite $nvs $amgn 
2017-06-06: #amgen regeneron, sanofi urge court to reverse ban on cholesterol drug. read more:  $amgn|$amgn AT_USER  trying to rebuild biotech had a nice 3 day move, needs to hold the 200d for possible move to 16
Answer:
Rise